E-Medicare Pharma
Online Medicine Pharmacy
0.00$
Osimertinib is a medication used in the treatment of certain types of cancers. It is available under the brand name Tagrisso and its generic brand name Tagrix. Each tablet typically contains 80 milligrams (mg) of the active ingredient. The medication works by inhibiting specific enzymes involved in cancer growth. It is administered orally, usually once daily, and is available by prescription in E-Medicare Pharma
Attribute | Information |
---|---|
Generic Name | Osimertinib |
Brand Name | Tagrisso |
Generic Brand | Tagrix |
Dosage | 80 milligrams (mg) per tablet |
Quantity | 30 tablets per pack |
Indications | Treatment of certain types of cancers. Non-small cell lung cancer (NSCLC) |
Mechanism of Action | Inhibits specific enzymes involved in cancer growth |
Administration | Oral administration, usually once daily |
Availability | E-Medicare Pharma. An Online Pharmacy |
Tagrisso (Osimertinib) 80mg is a groundbreaking medication in the fight against certain types of cancer, particularly non-small cell lung cancer (NSCLC). It’s a beacon of hope for many patients and a prime example of how targeted therapy can change lives. Let’s dive into what makes Tagrisso so special and how it’s used in cancer treatment.
Tagrisso, also known by its generic name Osimertinib, is a type of targeted cancer therapy. It falls under the category of epidermal growth factor receptor (EGFR) inhibitors. This drug was developed to combat cancers that have specific mutations, making it a tailored treatment option rather than a one-size-fits-all approach.
How does Tagrisso work? It specifically targets and binds to the mutated forms of the EGFR gene, which are often present in cancer cells. By inhibiting these mutations, Tagrisso can effectively slow down or even stop the growth of cancer cells. This precision makes it incredibly effective for patients with these specific genetic alterations.
Tagrisso is primarily used to treat non-small cell lung cancer (NSCLC) with certain EGFR mutations. It is approved for use in both the first-line treatment of NSCLC and for patients who have progressed after treatment with other EGFR inhibitors. This makes it a versatile tool in the oncologist’s arsenal.
The standard dosage of Tagrisso is 80mg once daily. It can be taken with or without food, which adds to its convenience. Consistency is key, so taking it at the same time each day is recommended to maintain steady levels in the bloodstream.
Clinical trials have shown impressive results with Tagrisso. Patients treated with this drug often experience longer progression-free survival compared to those on other treatments. Success stories from these trials and real-world applications highlight Tagrisso’s effectiveness in managing and controlling NSCLC.
Like any medication, Tagrisso comes with potential side effects. Common ones include diarrhea, rash, dry skin, and nail issues. More serious but less common side effects can affect the heart and lungs, so regular monitoring by healthcare providers is essential. Managing side effects often involves supportive care and sometimes dose adjustments.
Tagrisso can interact with other medications, potentially altering its effectiveness or increasing side effects. Known interactions include certain antibiotics, antifungals, and medications that affect liver enzymes. It’s crucial to inform your healthcare provider about all medications and supplements you are taking to avoid adverse interactions.
There are certain populations for whom Tagrisso may not be suitable. This includes individuals with a history of interstitial lung disease or severe heart problems. Pregnant or breastfeeding women should also avoid Tagrisso due to potential risks to the baby.
Tagrisso can be expensive, with prices varying depending on location and insurance coverage. However, many insurance plans do cover it, and there are financial assistance programs available to help reduce the cost burden on patients.
Several support programs exist to help patients manage the cost and complexities of treatment. These programs offer financial assistance, counseling, and educational resources to ensure patients have the support they need throughout their treatment journey.
When compared to other EGFR inhibitors, Tagrisso stands out due to its efficacy and the specific mutations it targets. Its ability to penetrate the central nervous system (CNS) also gives it an edge in treating brain metastases, a common complication in advanced lung cancer.
Ongoing research continues to explore new uses for Tagrisso, including its potential in other cancer types and combination therapies. Future directions also focus on overcoming resistance mechanisms to extend its benefits to a broader patient population.
Hearing from patients who have experienced the benefits of Tagrisso can be incredibly inspiring. Many patients report significant improvements in their quality of life and overall health, providing hope and encouragement to others facing similar battles.
Tagrisso (Osimertinib) 80mg is a powerful tool in the fight against NSCLC, offering targeted treatment that has transformed many lives. With its high efficacy, manageable side effects, and ongoing research, it continues to be a cornerstone in modern oncology.
What is Tagrisso used for?
Tagrisso is used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations.
How long can you stay on Tagrisso?
Patients can stay on Tagrisso as long as it remains effective and the side effects are manageable, often for several years.
Can Tagrisso cure lung cancer?
While Tagrisso is not a cure, it can significantly control the disease and improve survival rates in many patients.
What should I avoid while taking Tagrisso?
Avoid grapefruit and grapefruit juice as they can affect how the medication works. Always discuss any new medications with your doctor to prevent interactions.
How do I get financial assistance for Tagrisso?
Several patient support programs and financial assistance options are available. Talk to your healthcare provider or visit the Tagrisso website for more information.
Whats the price of Tagrix 80mg ? The price of Tagrix is $500
Product Name | Tagrix |
---|---|
Generic Name | Osimertinib |
Formulation | Tablet |
Available Pack size | 30’s |
Strengths | 40mg & 80mg |
Previous Product
Next Product
Begin your journey to better health . Join now to unlock exclusive tips and insights sent straight to your inbox, empowering you to embrace a healthier lifestyle each and every day.
Online Medicine Pharmacy
+8801929123476 emedicarepharma@gmail.com
65, mymansingh High-way, Dhaka-1230, Bangladesh